Moreover, higher injection frequencies of NPH compared with glargine insulin may also contribute to a higher likelihood of BI discontinuation of NPH users than glargine users.26 And less hypoglycaemia caused by glargine, especially during the night, might also partly explain those findings.27, 28. This evidence concerns the gene INS and Hypoglycemia.